Ozempic 8 mg/3 mL (2.68 mg/mL) prefilled pen Images
Generic Name: semaglutide
This medication has been identified as Ozempic 8 mg/3 mL (2.68 mg/mL) prefilled pen. It is supplied by Novo Nordisk.
Ozempic is used in the treatment of Cardiovascular Risk Reduction; Diabetes, Type 2 and belongs to the drug class Incretin Mimetics (GLP-1 Agonists). Ozempic 8 mg/3 mL (2.68 mg/mL) prefilled pen is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Ozempic
- Generic Name
- semaglutide
- Strength
- 8 mg/3 mL (2.68 mg/mL) prefilled pen
- Availability
- Prescription only
- Drug Class
- Incretin Mimetics (GLP-1 Agonists)
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novo Nordisk
- National Drug Code (NDC)
- 00169-4772
More about Ozempic (semaglutide)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,212)
- Drug images
- Latest FDA alerts (3)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: Incretin Mimetics (GLP-1 Agonists)
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
